Parkinson’s Disease Stem Cell Research
The NYSCF Research Institute leverages the power of stem cell technology to generate disease models of the actual neurons actually affected by Parkinson’s disease. NYSCF Research Institute scientists utilize induced pluripotent stem (iPS) cell lines, and cells derived from them, to generate Parkinson’s patient-specific disease models, including the actual dopamine producing neurons that deteriorate and function improperly in this disease. These models represent the genetic diversity of those affected by the disease and enable scientists to study the underlying biology of the disease, the role of genetic and environmental risk factors, and to find new treatments and cures.
Parkinson’s Disease Stem Cell News & Resources
At NYSCF’s Eighth Annual Translational Stem Cell Research Conference, the CEO of the New York Stem Cell Foundation, Susan...